WHO ICTRP trial
The effect of bupivacaine with adrenaline in comparison with bupivacaine with…
IRCT20190715044224N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20190715044224N1 |
|---|---|
| Public title | The effect of bupivacaine with adrenaline in comparison with bupivacaine with neostigmine in induction of spinal anesthesia in TURP surgery |
| Scientific title | Evaluation the effect of bupivacaine with adrenaline in comparison with bupivacaine with neostigmine in induction of spinal anesthesia in TURP surgery |
| Primary sponsor | Islamic Azad University |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Benign prostate Hyperplasia. Enlarged prostate |
| Interventions | Intervention 1: Intervention group: The first group of will receive bupivacaine (ASTrazeneca Company) at a dose of 5 mg with adrenaline (Daro Pakhsh Company) at a dose of 0.1 to 0.2 cc will be administered for spinal anesthesia two to five… |
| Registration date | Aug 16, 2019 |
| Target size | 100 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: